GKOS

Glaukos (GKOS) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.

Earnings

Glaukos earned $2.0 million in the third quarter despite a $14.1 million settlement, then took on a $10.0 million license and a Huntsville plant.

Earnings

Record third-quarter sales of $211.0 million, led by the iDose TR implant and Epioxa, turned a year-earlier loss into a small profit.